Recent FDA Drug Approvals
The Food and Drug Administration (FDA) approved the following oncology drugs:
- FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma
- FDA Approves Lorlatinib for Metastatic ALK-positive NSCLC
- FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma
Visit the FDA Hematology/Oncology (Cancer) Approvals & Safety Notifications webpage for a list of current and past approvals.